Table 2.
Clinical and biochemical characteristics of the female subjects
| TG/HDL-C quartiles in females | |||||
|---|---|---|---|---|---|
|
| |||||
| Q1 (< 0.47) (n = 151) | Q2 (0.47-0.66) (n = 139) | Q3 (0.67-1.02) (n = 140) | Q4 (> 1.02) (n = 142) | P-value | |
| Age (years) | 39 (35-45) | 40 (36-44) | 40 (36-47) | 44 (38-53) | 0.001 |
| BMI (kg/m2) | 21.0 ± 2.7 | 21.7 ± 2.7 | 22.9 ± 3.2 | 24.1 ± 3.2 | 0.001 |
| Systolic BP (mmHg) | 109.6 ± 10.6 | 113.1 ± 11.4 | 113.0 ± 10.1 | 116.4 ± 10.9 | 0.001 |
| Diastolic BP (mmHg) | 65.3 ± 8.2 | 67.2 ± 8.2 | 67.5± 7.7 | 70.1 ± 8.2 | 0.001 |
| Fasting glucose (mmol/l) | 4.96 ± 0.38 | 5.02 ± 0.38 | 5.12 ± 0.45 | 5.22 ± 0.50 | 0.001 |
| Total cholesterol (mmol/l) | 5.04 ± 0.99 | 5.05 ± 0.89 | 5.23 ± 0.96 | 5.46 ± 1.04 | 0.001 |
| LDL-C (mmol/l) | 2.66 ± 0.74 | 2.79 ± 0.66 | 3.00 ± 0.72 | 3.08 ± 0.79 | 0.001 |
| HDL-C (mmol/l) | 1.79 (1.51-2.06) | 1.54 (1.34-1.76) | 1.40 (1.25-1.63) | 1.20 (1.08-1.36) | 0.001 |
| Triglycerides (mmol/l) | 0.6 (0.53-0.71) | 0.9 (0.74-1.02) | 1.12 (0.98-1.35) | 2.02 (1.61-2.6) | 0.001 |
| Uric acid (mg/dl) | 279.8 ± 67.8 | 280.5 ± 63.3 | 299.5 ± 65.2 | 311.8 ± 76.6 | 0.001 |
| eGFR | 77.6 ± 15.3 | 81.8 ± 16.6 | 82.7 ± 18.4 | 81.1 ± 17.0 | 0.054 |
| Mean ABI | 1.07 ± 0.06 | 1.08 ± 0.08 | 1.07 ± 0.07 | 1.10 ± 0.07 | 0.004 |
| High baPWV (%) | 7.3% | 12.8% | 15.1% | 26.5% | 0.001 |
BMI, Body mass index; BP, blood pressure; LDL-C, LDL cholesterol; HDL-C, HDL cholesterol; eGFR, estimated glomerular filtration rate; ABI, ankle-brachial index; baPWV, brachial-ankle pulse wave velocity.